Hedgehog inhibition prolongs survival in a genetically engineered mouse model of pancreatic cancer

Feldmann, G.; Habbe, N.; Dhara, S.; Bisht, S.; Alvarez, H.; Fendrich, V.; Beaty, R.; Mullendore, M.; Karikari, C.; Bardeesy, N.; Ouellette, M. M.; Yu, W.; Maitra, A.
October 2008
Gut;Oct2008, Vol. 57 Issue 10, p1420
Academic Journal
Background and aims: Pancreatic cancer is among the most dismal of human malignancies. Current therapeutic strategies are virtually ineffective in controlling advanced, metastatic disease. Recent evidence suggests that the Hedgehog signalling pathway is aberrantly reactivated in the majority of pancreatic cancers, and that Hedgehog blockade has the potential to prevent disease progression and metastatic spread. Methods: Here it is shown that the Hedgehog pathway is activated in the Pdx1 -Cre; LsL-KrasG12D; Ink4a/Arflox/lox transgenic mouse model of pancreatic cancer. The effect of Hedgehog pathway inhibition on survival was determined by continuous application of the small molecule cyclopamine, a smoothened antagonist. Microarray analysis was performed on non-malignant human pancreatic ductal cells overexpressing Gli1 in order to screen for downstream Hedgehog target genes likely to be involved in pancreatic cancer progression. Results: Hedgehog inhibition with cyclopamine significantly prolonged median survival in the transgenic mouse model used here (67 vs 61 days; p = 0.0261. In vitro data indicated that Hedgehog activation might at least in part be ascribed to oncogenic Kras signalling. Microarray analysis identified 26 potential Hedgehog target genes that had previously been found to be overexpressed in pancreatic cancer. Five of them, BIRC3, COL11A1, NNMT, PLAU and TGM2, had been described as upregulated in more than one global gene expression analysis before. Conclusion: This study provides another line of evidence that Hedgehog signalling is a valid target for the development of novel therapeutics for pancreatic cancer that might be worth evaluating soon in a clinical setting.


Related Articles

  • GENETICALLY ENGINEERED MICE: TOOLS TO UNDERSTAND CRANIOFACIAL DEVELOPMENT. Ignelzi Jr., Michael A.; Yi-Hsin Liu; Maxson Jr., Robert E.; Snead, Malcolm L. // Critical Reviews in Oral Biology & Medicine;1995, Vol. 6 Issue 3, p181 

    In this review, we provide a survey of the experimental approaches used to generate genetically engineered mice. Two specific examples are presented that demonstrate the applicability of these approaches to craniofacial development. In the first, a promoter analysis of the Msx2 gene is presented...

  • A Serial Analysis of Gene Expression Profile of the Alzheimer’s Disease Tg2576 Mouse Model. George, Amee J.; Gordon, Lavinia; Beissbarth, Tim; Koukoulas, Irene; Holsinger, R. M. Damian; Perreau, Victoria; Cappai, Roberto; Seong-Seng Tan; Masters, Colin L.; Scott, Hamish S.; Qiao-Xin Li // Neurotoxicity Research;May2010, Vol. 17 Issue 4, p360 

    Serial analysis of gene expression (SAGE), a technique that allows for the simultaneous detection of expression levels of the entire genome without a priori knowledge of gene sequences, was used to examine the transcriptional expression pattern of the Tg2576 mouse model of Alzheimer’s...

  • Targeted Inactivation of p12Cdk2ap1, CDK2 Associating Protein 1, Leads to Early Embryonic Lethality. Yong Kim; McBride, Jim; Kimlin, Lauren; Eung-Kwon Pae; Deshpande, Amit; Wong, David T. // PLoS ONE;2009, Vol. 4 Issue 2, p1 

    Targeted disruption of murine Cdk2ap1, an inhibitor of CDK2 function and hence G1/S transition, results in the embryonic lethality with a high penetration rate. Detailed timed pregnancy analysis of embryos showed that the lethality occurred between embryonic day 3.5 pc and 5.5 pc, a period of...

  • Fluorescence-Guided Surgery in Combination with UVC Irradiation Cures Metastatic Human Pancreatic Cancer in Orthotopic Mouse Models. Hiroshima, Yukihiko; Maawy, Ali; Zhang, Yong; Sato, Sho; Murakami, Takashi; Yamamoto, Mako; Uehara, Fuminari; Miwa, Shinji; Yano, Shuya; Momiyama, Masashi; Chishima, Takashi; Tanaka, Kuniya; Bouvet, Michael; Endo, Itaru; Hoffman, Robert M. // PLoS ONE;Jun2014, Vol. 9 Issue 6, p1 

    The aim of this study is to determine if ultraviolet light (UVC) irradiation in combination with fluorescence-guided surgery (FGS) can eradicate metastatic human pancreatic cancer in orthotopic nude–mouse models. Two weeks after orthotopic implantation of human MiaPaCa-2 pancreatic cancer...

  • Transcriptional regulation of the interleukin-11 gene by oncogenic Ras. Shin, Soon Young; Choi, Chan; Lee, Hong Ghi; Lim, Yoongho; Lee, Young Han // Carcinogenesis;Dec2012, Vol. 33 Issue 12, p2467 

    Interleukin-11 (IL-11), which belongs to a class of IL6-type cytokines, plays an important role in inflammation, motility and invasion in cancer. The ras mutation is frequently found in human cancer, but little is known regarding the transcriptional activation of the IL-11 gene by the Ras signal...

  • Sulindac inhibits pancreatic carcinogenesis in LSL-KrasG12D-LSL-Trp53R172H-Pdx-1-Cre mice via suppressing aldo-keto reductase family 1B10 (AKR1B10). Li, Haonan; Yang, Allison L.; Chung, Yeon Tae; Zhang, Wanying; Liao, Jie; Yang, Guang-Yu // Carcinogenesis;Sep2013, Vol. 34 Issue 9, p2090 

    Sulindac has been identified as a competitive inhibitor of aldo-keto reductase 1B10 (AKR1B10), an enzyme that plays a key role in carcinogenesis. AKR1B10 is overexpressed in pancreatic ductal adenocarcinoma (PDAC) and exhibits lipid substrate specificity, especially for farnesyl and...

  • Sp1 expression regulates lung tumor progression. Hsu, T-I; Wang, M-C; Chen, S-Y; Yeh, Y-M; Su, W-C; Chang, W-C; Hung, J-J // Oncogene;8/30/2012, Vol. 31 Issue 35, p3973 

    The role of specificity protein 1 (Sp1) in controlling gene expression in lung tumor development and metastasis is not well understood. In this study, we showed that the Sp1 level was highly increased and required for lung tumor growth in transgenic mice bearing Kras-induced lung tumors under...

  • The Use of Knockout Mice Reveals a Synergistic Role of the Vav1 and Rasgrf2 Gene Deficiencies in Lymphomagenesis and Metastasis. Ruiz, Sergio; Santos, Eugenio; Bustelo, Xosé R. // PLoS ONE;2009, Vol. 4 Issue 12, p1 

    Background: Vav1 and RasGRF2 are GDP/GTP exchange factors for Ras superfamily GTPases with roles in the development and/or effector functions of T-lymphocytes. Methodology/Principal Findings: Given that the phenotype of Vav1-/-, Rasgrf2-/- and Vav1-/-;Rasgrf2-/- mice has been studied so far in...

  • List of transgenic and knockout mice: behavioral profiles. Bolivar, Valerie; Cook, Melloni; Flaherty, Lorraine // Mammalian Genome;Apr2000, Vol. 11 Issue 4, p260 

    A list of transgenic and knockout mice, having behavioral profiles, has been compiled. Behavioral and genetic information has been assembled in a simplified fashion so that the reader can easily determine the possible usefulness of each transgenic or knockout strain. Brief descriptions of the...


Read the Article


Sign out of this library

Other Topics